Shahrokh F. Shariat
ORCID: 0000-0002-6627-6179Also affiliated with Charles University, Al-Turath University, Comprehensive Cancer Center Vienna, University Hospital in Motol, Universitätszahnklinik Wien, Medical University of Vienna, The University of Texas Southwestern Medical Center
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 7 papers. Top paper: “Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma”.
J. Alfred Witjes, Jürgen E. Gschwend, Michael Schenker, Begoña P. Valderrama, Yoshihiko Tomita +24 more
R. Jeffrey Karnes, Michele Colicchia, Stephen A. Boorjian, Alberto Bossi, Thomas Seisen +19 more
Srinivas Nallandhighal, Jeffrey J. Tosoian, Kevin Hu, Trinh Pham, Judith Stangl‐Kremser +17 more
Carolin Siech, Letizia Maria Ippolita Jannello, Mario de Angelis, Natali Rodriguez Peñaranda, Zhe Tian +15 more
Reha-Baris Incesu, Simone Morra, Lukas Scheipner, Letizia Maria Ippolita Jannello, Mario de Angelis +14 more
Benjamin Pradère, Fahad Quhal, Keiichiro Mori, Ekaterina Laukhtina, Nicolai Huebner +9 more
Jeffrey J. Tosoian, Udit Singhal, Razeen Karim, Romain Mathiéu, Komal Plouffe +15 more